ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
73 hedge funds and large institutions have $44.8M invested in Adamas Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $62.1M → $44.8M (-$17.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
73
Holding in Top 10
–
Calls
$584K
Puts
$51K
Top Buyers
| 1 | +$2.45M | |
| 2 | +$2.16M | |
| 3 | +$757K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$704K |
| 5 |
JP Morgan Chase
New York
|
+$642K |
Top Sellers
| 1 | -$4.83M | |
| 2 | -$1.65M | |
| 3 | -$1.15M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$829K |
| 5 |
AC
Antara Capital
New York
|
-$640K |